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Abstract
Background: Acute and recurrent acute urticaria are often associated with multiple factors including infections and
recent data suggest a role for herpesviruses.
Objective: To test the null hypothesis, that is, there is no association of herpesvirus infections with urticaria.
Methods: Thirty-seven patients between one month and 15 years of age were age matched to 37 controls who were
healthy or had mild acute respiratory infections but without urticaria. Patients and controls were followed for 1 to 6
years. Diagnostic studies included DNA detection by real-time PCR for herpes simplex virus (HSV) types 1 and 2,
Epstein-Barr virus (EBV), cytomegalovirus (CMV) and human herpesvirus-6 (HHV-6). Tests for other infections
included adenovirus, parvovirus B 19, respiratory syncytial virus, influenza A, Group A streptococci, rotavirus, and
parasites.
Results: Specific infections were diagnosed in 26 of 37 cases and among 9 of 37 control children (P=0.0002). Single
or concomitant herpesvirus infections occurred in 24 cases and in 4 controls (65% vs 11 %, p=0.0003). Cases had
10 HHV-6 infections, 8 CMV infections, 5 EBV infections, and 4 HSV-1 infections.
Conclusion: Herpesvirus infections are associated with acute or recurrent acute urticaria.
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Introduction
Urticaria is a common skin reaction characterized by itchy
short-lived elevated erythematous wheals anywhere on the
skin. Acute urticaria is associated with symptoms for less than
6 weeks, and is considered to be recurrent acute if the duration
of symptom-free periods between urticaria episodes is longer
than 6 weeks [1]. Although a specific cause is not frequently
identified, the onset of acute urticaria has been associated with
allergic reactions to foods and drugs, contact with chemicals,
physical stimuli, or infections.
Nearly all of the numerous studies reporting evidence for
infectious agents triggering acute or recurrent acute urticaria
are retrospective observational studies without appropriate
controls or are case reports. Different studies reported a rate
ranging from 37% to 58% of multiple infections among 54 or 79
patients with acute urticaria, respectively [2,3]. Another study
highlighted the role of Mycoplasma pneumoniae infection,
which occurred in 32% of 65 children with acute urticaria [4].
Other reports focused on an association between acute
urticaria and streptococcal infection, hepatitis A and B viruses,
parvovirus B19, cytomegalovirus (CMV), coxsackie A9 virus,
enterovirus, influenza A and parainfluenza viruses [5-10]. Acute
urticaria has also been observed after influenza vaccination
[11]. Upper respiratory or digestive symptoms are common with
acute urticaria associated with infections [10,12,13]. These
studies do not provide a compelling case for causal link
between a specific infection and the development of urticaria.
Reports of herpesvirus infections are frequent but reports of
associated urticaria are few. We thus investigated the
association of herpes simplex virus (HSV) types 1 and 2,
Epstein-Barr virus (EBV), CMV and human herpesvirus-6
(HHV-6) with acute or recurrent acute urticaria.
Methods
Ethical statement
The study was approved by the local ethical committee
named Comitato Etico del Dipartimento di Medicina
Sperimentale e Sanità Pubblica, Università dell’Aquila,
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L’Aquila, Italy. Written consent was obtained from each subject
or their parent or guardian. The local ethical committee
approved the written consent process. Consent was
documented in writing.
Subjects
A prospective study was performed from November 1, 2005
to October 30, 2010, and included 37 patients, 26 of whom
were outpatients and 11 were hospitalized due to a first attack
of acute urticaria. All patients had a physical examination and
history that included time of onset of disease, frequency
duration size and distribution of wheals, diurnal variation,
shape, associated angioedema, family history of urticaria and
atopy, previous or current allergies, infections, gastric/intestinal
problems, use of drugs, and correlation to food. The diagnosis
of urticaria was made by the appearance of circumscribed,
slightly elevated, erythematous, edematous papules or wheals.
Lesions varied from moment to moment and disappeared
within minutes or hours. As controls 37 children who were
healthy or had mild acute respiratory infections, who were
predominantly siblings or playmates of the patients, were age-
matched to within one year of the cases and had the same
diagnostic studies. Both cases and controls were followed
every 3 to 6 months for 1 to 6 years (mean: 4.2 years and 3.8
respectively).
Laboratory investigations
Laboratory tests at enrollment for cases included complete
blood counts, platelets, erythrocyte sedimentation rate (ESR),
C-reactive protein (CRP), aspartate transaminase (AST),
alanine transaminase (ALT), and urine examination. In all
cases serum immunoglobulin (IgG, IgA, IgM, IgE) were
examined.
In both cases and controls at enrollment EBV-DNA, CMV-
DNA and HHV-6-DNA were detected in the serum and saliva
with the use of Real-Time polymerase-chain-reaction. IgG and
IgM antibodies against HSV, EBV, CMV, and HHV-6 were
examined in serum samples, using commercial enzyme-linked
immunosorbent assay from Radim (Pomezia, Italy) and Sorin
(Saluggia, Italy). A viral infection was considered as active if
high levels of virus-specific IgM antibodies were initially
detected with an increase in concentration of viral specific IgG
antibodies or HSV-1/2, EBV, CMV or HHV-6 DNA was
detected in at least one sample. Other enrollment studies for
cases and controls included IgG and IgM anti-adenovirus,
respiratory syncythial virus, influenza virus and parvovirus B19
as well as rotavirus detection in the stools. Group A
streptococcal infection was diagnosed if a throat swab was
positive and/or a significant ASO increase (≥ double of
previous one) occurred. Specific IgG and IgM antibodies
towards Mycoplasma and Chlamydia pneumoniae were
performed in children with upper respiratory infections.
Helicobacter pylori and specific IgG antibodies were tested for
in children with recurrent abdominal pain.
Allergic studies included skin prick and total and specific IgE.
Skin test was determined by using undiluted commercial
allergens (cow’s milk, whole eggs, chocolate, tomato, grasses,
olive, Parietaria, Artemisia, Alternaria, Ambrosia, Betulla,
Dermatophagoides pteronyssinus, Dermatophagoides farinae,
Penicillium, dog, cat). A positive histamine control skin test was
performed. A positive skin test was defined as inducing a
reaction with a wheal size measuring 3 mm or more after
subtraction of the control value. Specific IgE antibodies to
bovine milk proteins (α-lactalbumin, β-lactoglobulin, and
casein) was determined by radioallergosorbent assay (RAST).
Statistical analysis
Statistical analyses were done in part with JMP8.0 (SAS
Institute Inc.). McNemar’s chi square tests were used for paired
comparisons. Variables with a univariate P value of <0.2 were
included in a logistic regression model. Multinomial logistic
regression to analyze a 1-1 matched case-control study was
performed using IBM SPSS Statistics Version 19 (2010, SPSS
Inc).
Results
Clinical manifestations of urticaria
Tables 1 and 2 describe the characteristics of cases and
controls. The mean age of the cases and controls was 3.8
years (Table 3) with a range from 1 month to 15 years. Twenty
of 37 (54%) cases had a single episode of acute urticaria, and
the remaining 17 (46%) had recurrent acute urticaria. While
acute urticaria prevailed in children younger than 2 or older
than 6 years of age, recurrent urticaria occurred more
frequently in children between 2 and 6 years (p <0.05).
Urticaria was associated with other clinical manifestations in 27
cases (73%).
Laboratory and immunologic findings
Fifteen cases had elevated leukocytes (>9.1×103/mm3) which
ranged from 4.47×103/mm3 to 34.7×103/mm3 (mean values
10.27×103/mm3) and of these 14 also had lymphocytosis. Ten
cases had eosinophilia (> 1500 eosinophils/mm3). Seven cases
had increased platelets (> 450×103/mm3), 7 had an elevated
ESR; 2 had an elevated CRP (>0.5 mg/l); 3 had abnormal ALT
and AST levels . Immunoglobulin, C3 and C4 levels were
normal in all cases.
Risk factors
Ten cases (37%) had past allergic manifestations (Table 1).
Six cases had increased levels of specific IgE antibodies
towards cow’s milk, egg, Dermatophagoides pteronissimus/
farinae. One case had an increased level of total IgE
antibodies. Only two cases had positive skin prick tests to
Graminaceae. Ibuprofen was the possible cause of acute
urticaria in only one case.
Virologic findings
Specific infections were diagnosed in 26 of 37 cases and
among 9 of 37 control children (70% vs 24%; P=0.0002). Of
infected cases, 25 had viral infections, six had viral-bacterial
co-infections, six were infected with two viruses, and one had
M. pneumoniae infection. Two or more infections occurred in 7
of 17 cases (41%) who had recurrent urticaria compared with
Herpesvirus-Associated Urticaria
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Table 1. Clinical manifestations and infections in children with acute or acute recurrent urticaria.
Cases  Gender  Age (years)  Urticaria
Clinical disease
concurrent with urticaria
Infections concurrent
with urticaria
Positive diagnostic
tests  Allergic data Hospital days
1. M 1.1 Acute Herpes labialis HSV-1 IgM RAST: cow's milk 0.55 kU/L none
2. M 1.3 Acute Pneumonia none None Atopic dermatitis none
3. M 4 Acute Gastroenteritis GAS* ASO 1375 IU/ml Total IgE 181 kU/L 6
     HHV-6 DNA saliva   
     Rotavirus Antigen in stools   
4. F 7 Acute recurrent Pneumonia M. pneumoniae IgM  8
     EBV IgM   
5. M 7.5 Acute recurrent Pharyngotonsillitis EBV DNA blood/saliva RAST: cow's milk 0.36 kU/L none
6. F 11 Acute Pneumonia M. pneumoniae IgM  5
7. F 5.4 Acute recurrent none CMV DNA urine  none
     ParvovirusB19 IgM   
8. M 6.2 Acute recurrent PharyngotonsillitisAbdominal pain GAS ASO 690 IU/ml Atopic dermatitis none
     H.Pylori Antigen in stools   
     EBV IgM   
9. M 4.8 Acute recurrent none none none  3
10. M 2 Acute recurrent Pneumonia Adenovirus IgM Atopic dermatitis 4
11. F 2 Acute none HHV-6 DNA saliva Rhinitis none
12. F 11 Acute Pharyngotonsillitis CMV IgM Wheezing Prick:Graminaceae+ none
13. M 3.6 Acute Gastroenteritis CMV IgM none 3
14. M 1.6 Acute Nasal herpes EBV IgM, DNA blood/saliva none 5
     HSV-1 IgM   
15. M 4.5 Acute Abdominal pain none none Wheezing 3
16. F 2.5 Acute recurrent Otitis HHV-6 DNA blood/saliva Wheezing 4
17. M 7 Acute recurrent Epididymitis none none none none
18. F 2.2 Acute recurrent none HHV-6 DNA blood/saliva none 4
     ParvovirusB19 IgM   
19. F 2 Acute Pharyngotonsillitis none none none none
20. M 2.3 Acute recurrent none none none none none
21. F 0.5 Acute recurrent none EBV DNA saliva RAST: cow's milk 2.1 kU/L none
22. F 8.1 Acute Pharyngotonsillitis none none Rhinitis Prick: Graminaceae+ none
23. M 3 Acute none none none none none
24. F 2.4 Acute recurrent Pharyngotonsillitis CMV DNA blood/saliva Atopic dermatitis none
     HHV-6 IgM   
25. F 0.4 Acute recurrent none HHV-6 DNA saliva Atopic dermatitis none
26. M 0.7 Acute recurrent PharyngotonsillitisGastroenteritis HHV-6 DNA blood/saliva none none
27. F 1.0 Acute Wheezing none none none none
28. F 3 Acute Pharyngotonsillitis HHV-6 IgM none none
29. M 1.0 Acute Pharyngotonsillitis none none none none
30. M 1.3 Acute none none none none none
31. M 8 Acute none CMV IgM none none
32. M 1.3 Acute Gingivostomatitis GAS ASO 601 IU/ml
RAST: D. pteronissinus
1.32 kU/L; D. farinae 0.8
kU/L
6
     HSV-1 IgM   
33. F 1 Acute Urinary tract infection HHV-6 IgM none none
34. M 2 Acute  none CMV IgM, DNA saliva RAST: egg 0.82 kU/L;cow's milk 0.76 kU/L none
35. M 5.8 Acute recurrent Aphtous stomatitis GAS ASO 552 IU/ml none none
     HSV-1 IgM   
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two or more infections in 2 of 20 cases (10%) who had only
one episode of urticaria (P =0.05).
The cases, compared to the age matched controls, had a
higher prevalence of herpesvirus infections: single or
concomitant herpesvirus infections occurred in 24 cases and in
4 controls (65% vs 11 %, p=0.0003, Table 3). Cases had 27
herpesvirus infections, including 10 HHV-6 infections, 8 CMV
infections, 5 EBV infections, and 4 HSV-1 infections (Table 1).
In 15 cases, 16 primary herpesvirus infections were identified
by high levels of specific IgM and increasing IgG antibodies.
One case was infected with two primary herpesvirus infections.
In 9 cases, 11 active nonprimary herpesvirus infections were
diagnosed by concomitant detection of specific DNA and high
levels of IgG. Two cases had concomitant primary and
nonprimary herpesvirus infections.
The only infections significantly associated with urticaria
were infections with one of the four herpesviruses, CMV, EBV,
HSV, or HHV-6 (Table 3). In a multinomial regression analysis
infections by HHV-6, HSV, and EBV were each independently
predictive of acute or recurrent urticaria and CMV approached
statistical significance (P = 0.1). None of the other infections
whether viral or bacterial approached statistical significance
(Table 3). Among 24 cases with a herpesvirus infection, 13
(54%) had recurrent acute urticaria compared with recurrent
acute urticaria in 4 of 13 (31%) cases without a herpesvirus
infection (p = 0.3). Atopy or allergies were not statistically (p
=0.3) more frequent among cases with herpesvirus infections
(13/17 = 76%) than cases without (11/20 =55%).
Discussion
Acute urticaria occurs in 15% to 25% of people at a some
point in their life, being associated with transudation of fluid
from skin blood vessels and release of mediators from
cutaneous mast cells and basophils [14] The release of mast
cell-derived mediators may be caused by both immune and
non immune mechanisms [15]. The association of acute
urticaria with atopy is common, being found up to 50% of the
cases and occasionally associated with an increase in total IgE
level, which may represent a nonspecific marker of the immune
mechanisms involved in urticaria rather than a sign of
underlying atopy [12].
In children, acute urticaria is often considered as a food or
drug allergy, leading to frequently unnecessary diet restrictions
or elimination of drugs and administration of antihistaminic or
corticosteroids. Identification of the true casual factors for
urticaria would be very helpful in the management and
prognosis. Possible causes, however, are numerous having
been reported in between 21% to 83% of cases [2,16]. This
high variability is due to the various criteria used in evaluating
the causes and the enrollment criteria. The various criteria
used have included acute or chronic infections, non allergic
hypersensitivity reactions to foods and drugs, and
autoimmunity mediated by functional autoantibodies directed
against the IgE receptors [13,17–19]. Between 37% and 58%,
of children with acute urticaria also have infections, usually
virus-induced upper respiratory infections [2,3]. Viral infections
have also been associated to the onset of atopic
manifestations and an increase in systemic IgE levels [20].
Infections, however, frequently also occur in patients with drug
allergies making it difficult to distinguish between the two
possible causal factors [16].
Ours is the first prospective age-matched case-control study
to evaluate the association between acute or recurrent acute
urticaria and a broad range of infectious causes in children.
One previous study reported a 32% rate of M. pneumoniae
infections among 65 children but a so called control group of 49
children with respiratory infections was not tested for M.
pneumoniae. We found no evidence that acute urticaria was
associated with Mycoplasma or streptococcal or respiratory
viral infections. We did however observed that the onset of
acute urticaria was strongly associated with an herpesvirus
infection, including children who developed recurrent acute
urticaria. Herpesviruses can persist long life alternating latent
and reactivation phases, thus primary or reactivated
herpesvirus infections may be associated with acute or
recurrent acute urticaria. Cellular immunity controls herpesvirus
infections and both primary and recurrent infections are
associated with altered cell-mediated responsiveness and
production of a number of cytokines [21]. As occurs in virus-
induced asthma exacerbations after viral induction of mast cell
activation, the activation of mast cells may be involved in
herpesvirus-induced diseases, including the urticaria in
genetically predisposed children [15,22].
HHV-6, CMV and EBV infections are common in children. In
particular the seroprevalence rate of HHV-6 is between 80%
and 100% by the age of 3 years [23]. HHV-6 usually causes
exanthema subitum but can affect the immunosurveillance
Table 1 (continued).
Cases  Gender  Age (years)  Urticaria
Clinical disease
concurrent with urticaria
Infections concurrent
with urticaria
Positive diagnostic
tests  Allergic data Hospital days
36. F 0.3 Acute recurrent none CMV IgM, DNA saliva  RAST: cow's milk 1.63kU/L  
37. F 8.1 Acute recurrent Pharyngotonsillitis GAS Pharyngeal swab: GAS,ASO 477 IU/ml none 5
     HHV-6 DNA saliva   
     CMV IgM   
GAS = Group A β-hemolytic Streptococcus
doi: 10.1371/journal.pone.0085378.t001
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system because of its tropism for T lymphocytes, monocytes/
macrophages, and dendritic cells. In fact, HHV-6 stimulates the
Table 2. Characteristics of healthy controls.
Controls  Gender  
Age
(years)  
Subclinical
findings
Positive
infectious
tests Allergic data
1. M 1.9 none none none
2. F 1.1 none none none
3. M 3.8 none none none
4. M 7.1 GAS ASO 502 none
5. F 7.8 none none none
6. M 10.1 GAS ASO 748 none
7. M 5.1 none none none
8. M 6 GAS ASO 630 none
9. M 4.3 none none none
10 F 2.5 GAS ASO 440 none
   HHV-6 DNA saliva  
11. F 2.1 CMV DNA salivaurine none
12. F 11 none none none
13. M 3.2 none none none
14. F 1.3 none none none
15 M 3.8 none none RAST: cow's milk 2.9kU/L
16. F 2.8 none none none
17 F 7.6 none none none
18. F 2.3 none none none
19. F 2.1 HHV-6 DNA saliva none
20. M 2.7 Adenovirus IgM none
21. M 0.7 none none Atopic dermatitis
22. M 9.5 GAS ASO 361 RAST: cow's milk 1.6kU/L
   CMV DNA saliva/urine  
23. M 2.8 GAS ASO 383 none
24 F 2.8 none none none
25. M 0.8 none none none
26. M 0.9 none none none
27. M 1.4 none none none
28 M 3.1 none none Atopic dermatitis,Asthma
29. M 1.3 none none Atopic dermatitis Pricktest: D. pteronissinus
30. M 1.7 none none none
31. M 7.4 GAS ASO 893 none
32. F 11.6 none none none
33. M 1.9 none none none
34. M 0.1 none none none
35. F 5.7 none none none
36. F 0.6 none none none
37. M 10.4 none none
Rhinoconjunctivitis
RAST: P. officinalis
3.45 kU/L
doi: 10.1371/journal.pone.0085378.t002
production of interferon-α and tumor necrosis factor-α, and
upregulates NK cell cytotoxicity via interleukin-15 [24,25]. CMV
infection is common both pre and postnatally with an overall
prevalence of between 15% and 25% among children, and also
has many effects on the immune system mostly via cell-
mediated immunity [21]. Eight children had persistent CMV
DNA detection for more than 3 months after acute urticaria: six
of these children developed recurrent acute urticaria. EBV and
HSV-1 infections also stimulate cellular and antibody immune
responses [21,26]. Caubet et al. recently reported on a viral
trigger, including acute EBV infections, for the urticaria or a red
rash in 54/82 (66%) patients presenting to an emergency room
with a negative oral challenge test (OCT). Interestingly, 3 of the
Table 3. Comparison of cases and controls for possible risk
factors for urticaria.
Characteristics
Cases
Disease
N= 37
Controls
No
disease    
N =37
Univariate
P value
Multivariate     P
value (adjusted
odd ratio, 95%
confidence
interval)
No of male cases 20 23 0.63 Not done
Mean age + SD of case
and controls (years) -
matching criteria
3.7+3.0 3.9+3.0 Not done Not done
No. of children with
CMV 8 2 0.12 0.10 (3.5, 0.67-19)
No. of children with
HSV 4 0 0.13 0.019
*
No. of children with
EBV 5 0 0.07 0.017
*
No. of children with
HHV-6 10 2 0.043
0.019 (5.1,
1.06-24.3)
No. of children with
Adenovirus 1 1 0.48 Not done
No .of children with any
herpes infection (CMV,
HSV, EBV, HHV)
24 4 0.0003 Not done
No. of children with
Parvovirus 2 0 0.48 Not done
No. of children with M.
Pneumoniae 2 0 0.48 Not done
No. of children with
Rotavirus 1 0 1.00 Not done
Number of children with
group A Streptococcal
infections
5 7 0.75 Not done
No. of children with
RAST/Prick 8 4 0.68 Not done
No. of children with
allergy or atopy 5 3 1.00 Not done
No. of children with
wheezing or rhinitis 5 1 0.22 Not done
* Too few subjects were infected to calculate an accurate odds ratio.
doi: 10.1371/journal.pone.0085378.t003
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patients with a positive OCT (50%) had findings suggestive of
an acute or recent EBV infection [27].
Herpesviruses are a component of the human "microbiome"
since they are adapted to lifelong infection of their hosts.
Recent evidence suggest a possible role for herpesviruses in
allergy and atopy [9]. Our results with urticaria and those with
allergic and atopic reactions suggest physicians caring for
allergic and atopic populations should be familiar with the
manifestations of herpes-related disease [27,28].
Because herpesvirus infections are common among children,
possible limitations of our study include the small sample size
and the practical limitation of only being able to obtain, in most
cases, single specimens for diagnostic testing. Perhaps more
subjects and repetitive testing would skew the results.
Nevertheless with a significantly higher rate than controls, we
observed a herpesvirus infection in 65% of our patients which
suggests herpesviruses may be component of the process
involved in development of acute or recurrent acute urticaria.
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